Table 3.
Prediction model of DRG price based on the examined KEN-DRG: Proposal A
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
|---|---|---|---|---|---|---|---|
| R/N | KEN-DRG code | KEN-DRG description | Length of stay by KEN-DRG | KEN-DRG price | Base price | Proposed relative weights | Proposed DRG price |
| 1 | Π40Χ | Digestive malignancy W/O catastrophic CC | 3 | €600 | €2045 | 0.74 | €1520 |
| 2 | Σ20Μ | Acute leukaemia W catastrophic CC | 17 | €5707 | €2045 | 5.49 | €11,225 |
| 3 | Σ21Μ | Lymphoma and non-acute leukaemia W catastrophic CC | 14 | €3100 | €2045 | 3.41 | €6971 |
| 4 | Σ21Χ | Lymphoma and non-acute leukaemia W/O catastrophic CC | 5 | €1410 | €2045 | 0.72 | €1462 |
| 5 | Α31Χ | Respiratory neoplasms W/O catastrophic CC | 5 | €828 | €2045 | 1.38 | €2826 |
| 6 | Η41Χ | Malignancy of hepatobiliary system, pancreas W/O catastrophic CC | 4 | €792 | €2045 | 0.66 | €1350 |
| 7 | Η41Μ | Malignancy of hepatobiliary system, pancreas W catastrophic CC | 9 | €1754 | €2045 | 1.60 | €3266 |
| 8 | Σ22Χ | Other neoplastic disorders W/O CC | 2 | €638 | €2045 | 0.50 | €1020 |
| 9 | Π40Μ | Digestive malignancy W catastrophic CC | 10 | €1100 | €2045 | 2.43 | €4971 |
| 10 | Α31Μ | Respiratory neoplasms W catastrophic CC | 9 | €1634 | €2045 | 2.14 | €4369 |
| 11 | Υ22Μ | Kidney and urinary tract neoplasms W catastrophic or severe CC | 7 | €1373 | €2045 | 2.28 | €4672 |
| 12 | Σ01Μ | Lymphoma and leukaemia W major OR procedures W catastrophic or severe CC | 23 | €8000 | €2045 | 6.25 | €12,790 |
| 13 | Γ20Χ | Malignancy, female reproductive system W/O catastrophic CC | 4 | €1100 | €2045 | 0.90 | €1843 |
CC Catastrophic or Severe CC, DRG diagnosis-related group, KEN-DRG Greek diagnosis-related group, LOS length of stay, R/N row number, W with, W/O without